PHARMA
Quarterly rpt on consolidated results for the financial period ended 30 Sep 2025
| PHARMANIAGA BERHAD |
| Financial Year End | 31 Dec 2025 |
| Quarter | 3 Qtr |
| Quarterly report for the financial period ended | 30 Sep 2025 |
| The figures | have not been audited |
- Default Currency
- Other Currency
Currency: Malaysian Ringgit (MYR)
SUMMARY OF KEY FINANCIAL INFORMATION
|
INDIVIDUAL PERIOD
|
CUMULATIVE PERIOD
|
||||
CURRENT YEAR QUARTER
|
PRECEDING YEAR CORRESPONDING QUARTER |
CURRENT YEAR TO DATE
|
PRECEDING YEAR CORRESPONDING PERIOD |
||
|
30 Sep 2025
|
30 Sep 2024
|
30 Sep 2025
|
30 Sep 2024
|
||
|
MYR'000
|
MYR'000
|
MYR'000
|
MYR'000
|
||
| 1 | Revenue |
1,007,263
|
1,029,822
|
2,989,476
|
2,833,037
|
| 2 | Profit/(loss) before tax |
10,357
|
138,485
|
63,294
|
180,863
|
| 3 | Profit/(loss) for the period |
7,491
|
101,319
|
41,952
|
131,344
|
| 4 | Profit/(loss) attributable to ordinary equity holders of the parent |
7,276
|
101,032
|
40,815
|
129,475
|
| 5 | Basic earnings/(loss) per share (Subunit) |
0.28
|
7.01
|
1.56
|
8.98
|
| 6 | Proposed/Declared dividend per share (Subunit) |
0.00
|
0.00
|
0.00
|
0.00
|
AS AT END OF CURRENT QUARTER
|
AS AT PRECEDING FINANCIAL YEAR END
|
||||
| 7 |
Net assets per share attributable to ordinary equity holders of the parent |
0.0650
|
-0.1188
|
||
Definition of Subunit:
In a currency system, there is usually a main unit (base) and
subunit that is a fraction amount of the main unit.
Example for the subunit as follows:
| Country | Base Unit | Subunit |
| Malaysia | Ringgit | Sen |
| United States | Dollar | Cent |
| United Kingdom | Pound | Pence |
Announcement Info
| Company Name | PHARMANIAGA BERHAD |
| Stock Name | PHARMA |
| Date Announced | 13 Nov 2025 |
| Category | Financial Results |
| Reference Number | FRA-12112025-00014 |